Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
for Diabetes Mellitus, Type 1
57 locations incl. Scottsdale
Sponsor: vTv Therapeutics
Sex: All·Age: 18+
Code: NCT06334133·Phase 3·Recruiting·Listed Mar 2024
Clinical research site in Reno, Nevada
Part of Vector Clinical Trials
As of July 2026, 1 paid clinical trial is recruiting at Vector Clinical Trials in Reno, Nevada. Active studies at this site focus on Diabetes Mellitus, Type 1 alongside other indications. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .